Cannabis News
White House Drug Strategy Shows Trump Administration’s Conflicts On Marijuana And Other Issues, Experts Say
“On the one hand, the administration is moving in the direction of liberalizing access to cannabis, but at the same time, in the strategy, it talks about the risks of doing so.”
The White House’s newly released strategy to combat the nation’s drug and addiction crisis calls for some ambitious public health approaches that some experts say are laudable but will be hindered by the administration’s actions.
195 wide pages National Strategy for Drug Controlpublished on May 4, advocates making access to treatment easier than obtaining drugs, preventing young people from developing addictions in the first place, increasing support for people in recovery and reducing overdose deaths.
These broad goals are widely supported by public health researchers, addiction treatment clinicians, and recovery advocates.
But meeting such goals will be difficult for the administration mass layoffs of federal workers, cancel the investigation and community grants, attacks on institutions and practices which are useful for people who use drugs, and Medicaid cutsa state-federal health insurance program that is the nation’s largest payer of addiction and mental health care for low-income people.
Many of the components of the National Drug Control Strategy are “things that we would agree to and fully support”. Libby Joneswho leads overdose prevention efforts at the Global Health Advocacy Incubator, a public health advocacy group.
But “there are disconnects in terms of what’s important to the strategy and then what they’re actually going to fund,” he said of the Trump administration. “These inconsistencies are felt particularly loudly in this strategy.”
The White House’s National Drug Control Strategy has been released every two yearsit is a document that aims to define a coordinated approach to the federal government that has been one of the country’s defining issues in recent decades.
since 2000, More than 1.1 million people they have died of drug overdoses. Despite the deaths has decreased recentlythe number continues to rise compared to previous decades, and research suggests Overdose death rates for black Americans and Native Americans are disproportionately high.
The strategy document released this week is the first of President Donald Trump’s current term. In keeping with the administration’s approach to addiction issues, it places a strong emphasis on law enforcement efforts to reduce the supply of illegal drugs. The document repeatedly refers to a “war” against foreign “terrorist organizations” — the Trump administration’s term for drug cartels — and increased enforcement at US borders.
Also determines plans implementing artificial intelligence technologies to analyze illegal drugs brought into the country and wastewater testing to detect illegal drug use nationwide.
The second half of the strategy focuses on reducing the demand for drugs, supporting public health prevention efforts, addiction treatment, and helping people in recovery. Religion promotes the role of recovery and the widespread use of overdose reversal drugs such as naloxone.
In a news release, the White House Office of National Drug Control Policy called the document a “road map” that will “continue to dismantle our nation’s drug supply and defeat the scourge of illegal drugs.”
The Trump administration did not respond to requests for comment on how the strategy fits with its other actions.
In December, Trump signed one Reauthorization of the HELP Actcontinues with various treatment and recovery-related subsidies and the requirement that Medicaid cover all FDA-approved medications for opioid use disorders. He announced in January The Great American Recovery Initiativeincluding a 100 million dollar investment to combat homelessness, opioid addiction and public safety.
However, few details have been released about the initiative, and in January, about a month after the HELP Act was passed, billions of dollars in addiction-related grants suddenly became available. finish and reset In a frantic 24-hour period.
This “whirlwind” left a “sense of instability and uncertainty in the area”. Yngvild OlsenNational consultant for Manatt Health consulting. He led substance use treatment policy at the Substance Abuse and Mental Health Services Administration, or SAMHSA, under the Biden administration and left about six months into Trump’s second term.
Insecurity increased the president’s 2027 budget requestwhich proposes cutting various addiction and mental health programs and consolidating key federal agencies that work on these issues. Jones’ team and about 100 others in the field have done it he signed a letter Asking Congress to reject the proposals, as they did with similar requests last year.
The national drug strategy adds new and contradictory information to this confusing landscape.
Increasing access to treatment
One of the most significant public health goals in the strategy, mentioned at least half a dozen times, is to make treatment easier than buying illegal drugs.
National data underscores the need for: more than 80% of Americans those who need substance use treatment do not receive it.
The administration’s actions regarding health insurance may make it difficult to improve this statistic.
It’s Medicaid primary source of health coverage for adults with opioid use disorder. When implemented, the Medicaid work requirement in Trump’s One Big Beautiful Bill Act is expected to eliminate that coverage. About 1.6 million people with substance use disorders.
The last time the Medicaid rolls were purged was after that covid-era protections have expired – Many people who were receiving drugs for opioid addiction stopped and fewer people started treatment, according to one. research published last year.
Olsen, who is also an addiction medicine doctor, said she loves the strategy’s focus on making treatment readily available to anyone who wants it. But he said that’s “hard to really imagine when people might have to pay for it themselves because they might lose their Medicaid insurance coverage.”
Appreciate an analysis The upcoming Medicaid changes could cause 156,000 people to lose access to opioid use disorder medication and cause 1,000 more fatal overdoses a year.
People with private insurance may also be affected.
The Trump administration has he refused to enforce it Addressing the regulations of the Biden era strengthening mental health paritythe idea that insurance should cover mental illness and addiction treatment in comparison to physical treatments. And recently, the administration said that redo those regulations in total, raising fears that addiction treatment may become increasingly affordable.
The administration did not respond to specific questions about how it reconciles Medicaid and equity action with the goal of increasing treatment.
Prioritizing prevention
The strategy highlights that preventing addictions before they start is one of the keys to reducing drug demand. It calls for “promoting a drug-free America as the social norm” and implementing science-backed school and community-based programs.
“Investing in early prevention, before drug use starts, saves lives and resources,” he says, citing. several studies about cost effectiveness among such programs.
However, the president’s budget proposes cuts to these types of programs, and federal layoffs have decimated the agencies that would implement this work.
of the White House final quote request He proposes to cut approximately $220 million from SAMHSA Center for Substance Abuse Prevention and almost 40 million dollars Drug-free communities the program
Since the new administration began, SAMHSA has lost about half of the workforceand the Centers for Disease Control and Prevention about a quarter.
“It’s not clear to me that they’re going to have the funds or the people to make it happen,” Olsen said of the strategy’s prevention goals.
The strategy presents another wrinkle in the marijuana debate. The document points to marijuana use as one of the drivers of drug use disorders and “convergent evidence from multiple sources” suggests that cannabis use increases the risk of psychosis. It requires the development of new tools to treat marijuana withdrawal and addiction.
However, just two weeks ago, the White House led to reclassification medical marijuana is moving to and from a lower level of scheduled substances audition to do the same with marijuana.
“The administration, on the one hand, is moving in the direction of liberalizing access to cannabis,” Jones said, “but at the same time, strategically, it’s talking about the dangers of doing that.”
“There’s a disconnect there that begs the question: who do you think you are?” he added.
The administration did not respond to specific questions about its marijuana policies.
Stopping overdose deaths
One of the most surprising elements of the National Drug Control Strategy comes in the last paragraph of the last chapter. It focuses on public drug testing programs, which often use test strips to help people who use drugs determine whether their purchased lot contains more dangerous substances, such as fentanyl or xylazine. This helps them determine whether or not to use these drugs safely.
“Rapid test strips and similar technologies that detect fentanyl and other drugs are an important tool that should be legalized,” the strategy document says.
However, SAMHSA announced a last letter He said he would no longer pay for the test strips as part of the Trump administration’s “harm reduction and move away from practices that facilitate illegal drug use.”
The administration has also attacked harm reduction programs executive order and his the budget requests. He did not respond to specific questions about how that position affects the drug control strategy.
Regina LaBelleThe Georgetown University professor, who served as acting director of the Office of National Drug Control Policy in the Biden administration, wrote about the contradiction. a blog post: “It is the height of rhetoric over reality to defend an instrument while at the same time cutting off the funding used to acquire it.”
KFF Health News It is a national newsroom that produces in-depth journalism on health issues and is one of the core program drivers of KFF, an independent source of health policy research, surveys and journalism. Learn more KFF.
This the article appeared for the first time KFF Health News and is republished here under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License.
Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.
Existing medical cannabis licensing fees will be temporarily applied to recreational marijuana businesses, the Select Committee decided on May 5. Board members agreed 4-1 to the temporary change, as long as officials say the fees are higher than necessary and accurately reflect the town’s oversight costs.
Bryce Cobb, Livermore Falls’ code enforcement officer, plumbing inspector, health officer and E-911 dispatcher, said voters approved the amended cannabis ordinance on April 28. Cobb said the amended ordinance allows recreational marijuana businesses and the next step was to establish a fee schedule. Recreational cannabis businesses operating in town would require local licensing approval under the ordinance.
Asked if he had fee schedules from other towns to compare, Cobb said he did not. Additionally, the town’s fee schedule specifically mentions medicinal cannabis.
“So it could be medical and adult use,” Cobb said when discussing whether the existing fee structure could apply to recreational businesses.
Read more at Sun Magazine
Cannabis News
Georgia Governor Signs Bill To Expand Medical Marijuana Access By Allowing Vaping And Adding New Qualifying Conditions
The governor of Georgia has signed a bill expand access to medical marijuana in the state.
SB 220, which was approved by Gov. Brian Kemp (R) on Tuesday, will add new requirements to the program, allow patients to vape medical cannabis, and change THC potency limits, among other reforms.
Under the legislation, patients with lupus will be allowed access to medical marijuana, under current state law that allows people with cancer, Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, ALS, autism spectrum disorder, intractable pain and other conditions to qualify.
The bill by Sen. Matt Brass (R) removes many of the requirements for a patient to be in a critical or terminal condition to enter the medical cannabis program.
The reform will also expand how patients can use medical marijuana. Until now, they have been able to obtain oils, tinctures, capsules, lozenges, topicals and transdermal patches, but the new law will also allow vaping as a form of vaping for patients over 21, while continuing to ban smoking for all patients.
The Putting Georgia’s Patients First Act also replaces the current 5 percent THC potency limit on medical cannabis products with a limit of 12,000 milligrams of THC that a patient can possess at any one time.
“These changes, while meaningful to affected patients, do not materially change where Georgia stands in the national landscape on this issue,” Kemp said in a signing statement. “This bill passed with a constitutional majority in both houses of the General Assembly.”
“I, like many who opposed this bill, have reservations about legalizing recreational cannabis. Many states that have legalized recreational cannabis have regretted that decision,” he said. “I also recognize that for some patients, medical cannabis provides significant relief from symptoms that would otherwise be untreated or treated with even more harmful opioids.”
“I do not believe that a well-implemented medical cannabis program should inevitably lead to the legalization of recreational use in Georgia, nor is the issue of recreational use on the bill on my desk for signature,” the governor said.
The invoice also replaces references to “low THC oil” in current laws with “medical cannabis.”
—
It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.
Learn more about our marijuana bill tracking and become a Patreon supporter to gain access
—
The Georgia Medical Cannabis Access Commission, which oversees the program, “will have a new duty to inform citizens, law enforcement and health care providers about the effective uses of medical cannabis and its products, including publishing materials and conducting outreach and public education activities to inform the public, law enforcement and health care providers about this state’s medical cannabis program and the potential benefits for patients.”
Last year, the leaders of the Chamber a Blue-Ribbon Study Committee on Georgia’s Medical Marijuana and Hemp Policies to examine state cannabis laws.
Georgia lawmakers have also considered the legislation supporting research into the therapeutic benefits of psychedelics.
Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.
The growing tension between international scientific findings and US health policy has raised questions about whether Medicare beneficiaries are being exposed to cannabinoid products whose safety profiles have not been fully established.
In March 2026, the European Food Safety Authority (EFSA) carried out a formal scientific evaluation of a shipment of Charlotte’s Web hemp product, concluding that the safety of a carbon dioxide extract derived from Cannabis sativa L. “cannot be established”. The agency identified several gaps in the available data, including significant portions of the product remaining uncharacterized, a lack of reliable toxicological studies on the actual material, a lack of human clinical data, and an unknown allergenicity and long-term safety profile.
At the same time, the Centers for Medicare and Medicaid Services (CMS) launched the Substance Access Beneficiary Engagement Incentive (BEI) program. The initiative allows participating healthcare providers to discuss and supply certain hemp and marijuana-derived cannabinoid products to Medicare beneficiaries under the authority of the Center for Innovation, and does not require approval from the US Food and Drug Administration. That distinction is at issue in a pending federal case: Smart Approaches to Marijuana (SAM), et al. Robert F. Kennedy Jr. et al., Case 1:26-cv-01081 (U.S. District Court for the District of Columbia).
Under the FDA’s standard framework, products intended for therapeutic use typically undergo controlled clinical trials, dose standardization, safety and toxicology evaluation, and manufacturing and stability validation. The BEI program operates outside of this structure. Some observers point out that this could introduce products into federally funded care settings before those benchmarks are met, while proponents of the program characterize it as a legitimate model of innovation.
Medicare beneficiaries represent a medically complex population, with many patients managing multiple medications, chronic conditions, and increased susceptibility to drug interactions. Cannabinoid compounds, including THC, interact with metabolic pathways such as CYP450 enzymes, which process many common medications. The safety profile of these products in this population has not been fully characterized through controlled studies.
Following the launch of the program, several companies publicly announced their positioning within the emerging healthcare supply chain. Charlotte’s Web highlighted alignment with CMS drivers and Cornbread Hemp announced institutional distribution through a national group buying organization, reflecting broader commercialization activity in the category.
SAM v. In Kennedy, the court is evaluating whether CMS overstepped its statutory authority by introducing avenues for the supply of cannabinoids without formal regulations, public notice and comment, or FDA validation standards. A resolution will determine whether the program is scaled back, modified, or stopped pending further review as implemented.
The EFSA’s conclusion does not ban the marketing of CBD products, but indicates that the scientific evidence necessary to fully establish their safety remains incomplete. The political debate reflects a broader question in health care regulation: how to balance the pace of innovation for therapeutic products with the standards of evidence typically required in federally funded systems of care.
Source: MMJ International Holdings
Coast to Coast Cannabis News Reports on the B Block of Weed Talk News w/ Alaina Pinto
EXPLORING THE WORLD OF CANNABIS FESTIVALS | PETER HUSON
Michigan Cannabis Sales Fell Yet Again – New Cannabis Ventures
Livermore Falls debates cannabis licensing fees
Georgia Governor Signs Bill To Expand Medical Marijuana Access By Allowing Vaping And Adding New Qualifying Conditions
Target Adds Intoxicating Hemp Beverages to Stores in Florida, Texas, & Illinois
Ugly Dispensary in CT? You make the call! Plus reports from NJ, FL, MA, Missouri Recall…again
CANNABIS HIRING RECRUITMENT | BLUNTZ [CANNABIS JOBS]
EU regulators say Charlotte’s Web hemp CBD safety “cannot be established”
Trump’s Medical Marijuana Move Focused On Helping Ailing Seniors, But Lack Of Coordination Could Cause Backlash (Op-Ed)
“Our system can manage equipment across 10,000+ m² using just a few wires”
Florida Workshop to Discuss What Constitutes a ‘Cartoon’ in Hemp Packaging
Mazar-i-Sharif Hash Wednesday
Afghan Black Hash Wednesday
Re-release of the full show of Cannabis Coast to Coast news. Republican Texas DA Fires Up vs. laws;
Weak Michigan Cannabis Sales Again in July – New Cannabis Ventures
From Finance to Wellness: Brad Zerman’s Impactful Pivot
DEA’s Cole Reverses His “priorities” ; Prohibitionists Dig In; Dead & Co Celebrates 60 years in SF
Your Cannabis Business: Consistent Filings Are Critical
Texas DA Fires Up for Change! Mass. Sheriff arrested on Extortion charges; GOP vs Industry in state
-
Cannabis News9 months ago“Our system can manage equipment across 10,000+ m² using just a few wires”
-
Florida9 months agoFlorida Workshop to Discuss What Constitutes a ‘Cartoon’ in Hemp Packaging
-
Video7 months agoMazar-i-Sharif Hash Wednesday
-
Video7 months agoAfghan Black Hash Wednesday
-
Video9 months agoRe-release of the full show of Cannabis Coast to Coast news. Republican Texas DA Fires Up vs. laws;
-
aawh9 months agoWeak Michigan Cannabis Sales Again in July – New Cannabis Ventures
-
Video9 months agoFrom Finance to Wellness: Brad Zerman’s Impactful Pivot
-
Video9 months agoDEA’s Cole Reverses His “priorities” ; Prohibitionists Dig In; Dead & Co Celebrates 60 years in SF